UNITED STATES

 

 

SECURITIES AND EXCHANGE COMMISSION

 

 

Washington, D.C. 20549

 

 

 

 

SCHEDULE 13G

 

(Rule 13d-102)

 

Information to be Included in Statements Filed Pursuant to Rule 13d-1(b), (c)

and (d) and Amendments Thereto Filed Pursuant to Rule 13d-2.

 

Under the Securities Exchange Act of 1934
(Amendment No.     )*

 

NovaMed, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

66986W108

(CUSIP Number)

December 31, 2007

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

x

Rule 13d-1(b)

o

Rule 13d-1(c)

o

Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

Page 1 of 5



 

CUSIP No. 66986W108

 

 

1.

Name of Reporting Person
Geneva Investment Management of Chicago, LLC

 

 

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

Not Applicable

(a) o

 

 

 

(b) o

 

 

3.

SEC Use Only

 

 

4.

Citizenship or Place of Organization
Delaware

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5.

Sole Voting Power
1,257,760

 

6.

Shared Voting Power
None

 

7.

Sole Dispositive Power
1,257,760

 

8.

Shared Dispositive Power
None

 

 

9.

Aggregate Amount Beneficially Owned by Each Reporting Person
1,257,760

 

 

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o
Not Applicable

 

 

11.

Percent of Class Represented by Amount in Row (9)
5.1%

 

 

12.

Type of Reporting Person (See Instructions)
IA

 

Page 2 of 5



 

Item 1.

 

(a)

Name of Issuer
NovaMed, Inc.

 

(b)

Address of Issuer’s Principal Executive Offices
980 North Michigan Avenue, Suite 1620

Chicago, Illinois 60611

 

Item 2.

 

(a)

Name of Person Filing
Geneva Investment Management of Chicago, LLC (“Geneva”)

 

(b)

Address of Principal Business Office or, if none, Residence
Geneva is located at:

181 West Madison Street, Suite 3575

Chicago, Illinois 60602

 

(c)

Citizenship
Geneva is a Delaware limited liability company.

 

(d)

Title of Class of Securities
Common Stock

 

(e)

CUSIP Number
66986W108

 

Item 3.

Type of Person:

 

(e)

 

Geneva is an investment adviser registered under Section 203 of the Investment Advisers Act of 1940.

 

Page 3 of 5



 

Item 4.

Ownership (at December 31, 2007)

 

(a)

Amount beneficially owned within the meaning of rule 13d-3:

1,257,760

 

(b)

Percent of class:   

5.1% (based on 24,563,940 shares outstanding as of December 31, 2007)

 

(c)

Number of shares as to which the person has:

 

 

 

(i)

sole power to vote or to direct the vote:

1,257,760

 

 

(ii)

shared power to vote or to direct the vote:

None

 

 

(iii)

sole power to dispose or to direct the disposition of:

1,257,760

 

 

(iv)

shared power to dispose or to direct the disposition of:

None

 

Item 5.

Ownership of Five Percent or Less of a Class

Not applicable.

 

Item 6.

Ownership of More than Five Percent on Behalf of Another Person

The shares reported herein have been acquired on behalf of discretionary clients of Geneva.  Persons other than Geneva are entitled to receive all dividends from, and proceeds from the sale of, those shares.  None of those persons, to the knowledge of Geneva, has an economic interest in more than 5% of the class.

 

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person

Not Applicable

 

Item 8.

Identification and Classification of Members of the Group

Not Applicable

 

Item 9.

Notice of Dissolution of Group

Not Applicable

 

Page 4 of 5



 

Item 10.

Certification

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

Signature

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Date: April 1, 2008

GENEVA INVESTMENT MANAGEMENT OF CHICAGO, LLC

 

 


/s/ John Huber

 

Signature

 


John Huber/Principal

 

Name/Title

 

Page 5 of 5